Skip to main content
. 2019 Jan;16(1):79–85. doi: 10.2174/1567201815666180914095701

Fig. (3).

Fig. (3)

% release of MLT vs. time from formulations (a) CA1, CA2, PV1, HP1, HP2 and (b) CAPV1-CAPV5 at pH 1.2, with hard gelatin capsules, (c) CA1, CA2, PV1, HP1, HP2 and (d) CAPV1-CAPV5 at pH 6.8, with hard gelatin capsules, (e) CA1, CA2, PV1, HP1, HP2 and (f) CAPV1-CAPV5 at pH 6.8, with DRcapsTM capsules.